Skip to main content

Funding Opportunities

Pilot RFA's release

The Institute for Clinical and Translational Research (ICTR) offers annual funding to clinical and translational researchers at UW and throughout the state. The table below details the ICTR Award Programs for 2013-2014.  Individual RFAs and applications are available for each category.

 

RFA Award Program

Maximum $ /Time

Letter of Intent

Application Due

Basic & Clinical Translational Research Pilot Awards

$50,000/     

12 Months

2/1/2014

3/3/2014, 8 AM

Community & Clinical Outcomes Research Pilot

$75,000/

12 Months

1/14/2014

4/1/2014

Novel Therapeutics Discovery & Development Pilot Awards Program

$50,000/

12 Months

1/13/2014

NEW DATE

3/3/2014, 8 AM

Dissemination & Implementation Research Award Program

$150,000/

18-24 Months

1/14/2014

4/1/2014

Patient-Centered Outcomes Research (PCOR)

$100,000/

12 Months

1/14/2014

4/1/2014

Basic & Clinical Research Pilot Awards
We are requesting applications that address basic discovery activities (biological, social, behavioral mechanisms that underlie disease); development of biomarkers, target and lead molecules, and devices (mechanical, computational); preclinical and animal models; Proof of Concept studies; translation of discovery to patients (new diagnostic, treatment, and prevention methods, Phase 1, 2, and 3 clinical trials).
Projects funded in previous rounds.

Community & Clinical Outcomes Research Pilot (formerly known as the Type 2 Translational Research pilot)
This funding supports translational research that addresses the gap between what we know and what we do in clinical practice, community health programs, and the development of health policy. This includes the development of interventions that require individual, organizational, or system behavior change and their relationship to improvements in health, and comparative effectiveness research.
Projects funded in previous rounds.

Novel Therapeutics Discovery & Development Pilot Awards Program
UW ICTR strongly endorses recent campus initiatives that further the Wisconsin Idea by facilitating development of discoveries, as these complement our own efforts to improve human health. We are releasing a new RFA - Novel Therapeutics Discovery & Development Pilot Awards Program - that will provide support for discovery and development of new small molecules, biologics, devices, and diagnostics. Investigators will be invited to submit a full proposal based upon information requested in a mandatory letter of intent.

Dissemination & Implementation Research Award Program 
This new award program will provide support for research that addresses how to best ensure evidence-based strategies / interventions / programs are effectively delivered in clinical practice and community health programs.

Patient‐Centered Outcomes Research Award
Patient-Centered Outcomes Research (PCOR) is a new approach to research that focuses on engaging stakeholders throughout the research process as well as ensuring implementation and dissemination of research results. As such, many investigators lack the infrastructure, partnerships and preliminary data to apply for funding opportunities in this area. The goal of this RFA is to provide support for activities leading to a PCORI (Patient-Centered Research Outcomes Institute) application.

ICTR Novel Methods Awards Program

(November 1, 2013 Release Date)
The second round of our Novel Methods Awards Program has a new focus: projects that advance development of therapeutic discovery and development platforms. Applications must contain proposed methods and technologies that demonstrate compelling proof of principle in a specific field of application, and must be generally applicable (though not necessarily disease specific). The methods and technologies should not be project specific. Contact/Liaison: Peggy Hatfield (pmhatfieatwisc [dot] edu, 608-261-1939)

Mandatory Letter of Intent Receipt December 15, 2013
Application Receipt February 1, 2014
Peer Review February-March 2014
Committee Review March 2014
Award Announcement April 2014
Earliest Grant Start Date May 1, 2014
Request for Applications Materials (required for all award applicants)
Application Face Page (required for all award applicants)

ICTR Voucher Awards Program for Research Resources

(November 1, 2013 Release Date)
We are expanding our pilot portfolio to offer short-term, low dollar awards to advance the translation of discovery into therapy. Applicants must document an urgent need for services based upon recent extramural grant review, or milestones for therapeutic development. Requests are redeemable only at one of the ICTR-affiliated laboratories. Contact/Liaison: Peggy Hatfield (pmhatfieatwisc [dot] edu, 261-1939)

Applications Due December 1, 2013
Review Period December 2013
Awards Announced January 2014
Earliest Award Start Date: January 2014
Request for Applications Materials (required for all award applicants)
Application Face Page (required for all award applicants)

Eligibility of Lead Applicants:

  • Lead Applicants must be a UW-Madison faculty member or academic staff, sole or joint appointment (VA Hospital, UW-Milwaukee), or a Marshfield Clinic investigator. Eligible UW job titles include professor (tenure, CHS, or clinical track, all ranks); scientists with temporary or permanent PI status; and those with comparable Marshfield Clinic job classifications (Research Scientist).
  • Lead Applicants must have applied for membership to ICTR at Membership Application before submission of the grant application on December 1, 2013. Becoming a member is easy — simply fill out ICTR's Membership Application.
  • Include only one Lead Applicant per proposal.
  • Lead Applicants cannot currently be an ICTR KL2 and TL1 Scholar or Pilot Awardee.

Projects funded in first round of Voucher Awards Program 2013

Frequently Asked Questions
Questions about ICTR’s funding programs, eligibility, and general application, budget, and applicant requirements.

 

NIH Biosketch--Sample

Research Grant Terms & Conditions
Research grants awarded by ICTR are governed by the terms and conditions.